Kimberly R. Southern
Director Ejecutivo en Glauconix Biosciences, Inc. .
Perfil
Kimberly R.
Southern has held the following positions in her career: Chief Executive Officer at Glauconix Biosciences, Inc. since 2019, and President at QuadTech, Inc.
Cargos activos de Kimberly R. Southern
| Empresas | Cargo | Inicio |
|---|---|---|
QuadTech, Inc.
 QuadTech, Inc. Electronic Equipment/InstrumentsElectronic Technology QuadTech, Inc. manufactures test control products. The company is headquartered in Marlborough, MA. | Presidente | - |
Glauconix Biosciences, Inc.
 Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019. | Director Ejecutivo | 01/12/2019 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
QuadTech, Inc.
QuadTech, Inc. Electronic Equipment/InstrumentsElectronic Technology QuadTech, Inc. manufactures test control products. The company is headquartered in Marlborough, MA. | Electronic Technology |
Glauconix Biosciences, Inc.
Glauconix Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Glauconix Biosciences, Inc. is a company that specializes in developing ophthalmic ex-vivo dynamic 3D human tissue models for accelerating therapeutic innovation and drug discovery. The company is based in Albany, NY. The company's 3D tissue models can de-risk ophthalmic assets and expedite drug development, adding value to their clients and partners by expediting early identification and validation of effective compounds or biologics in the preclinical phase and those entering clinical trials. The company was founded in 2014 by Karen Torrejon, Feryan Ahmed. Kimberly R. Southern has been the CEO of the company since 2019. | Commercial Services |
- Bolsa de valores
- Insiders
- Kimberly R. Southern
